Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Back to school guide: Buses, lunches, key dates
Recommended
UNC has a new chancellor. Why interim Lee Roberts got the permanent job.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by DICE Therapeutics, Inc.
DICE Therapeutics to Host R&D Investor Event on Tuesday, June 20, 2023
June 13, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
May 11, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics to Participate in the Bank of America Securities 2023 Healthcare Conference
May 03, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
March 23, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
March 15, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics Announces Late-Breaking Presentation at the 2023 American Academy of Dermatology (AAD) Annual Meeting
March 01, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics to Participate at Upcoming Investor Conferences
February 08, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics Reports Third Quarter 2022 Financial Results and Recent Highlights
November 09, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics to Present at Upcoming Investor Conferences
November 03, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
October 17, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Announces Pricing of Upsized Public Offering of Common Stock
October 12, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Announces Proposed Public Offering of Common Stock
October 11, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
DICE Therapeutics Announces Positive Topline Data from Phase 1 Clinical Trial of Lead Oral IL-17 Antagonist, DC-806, for Psoriasis
October 11, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DICE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.